E. Perot Bissell
Acadia Healthcare CompanyAbout E. Perot Bissell
E. Perot Bissell, age 65, has served on Acadia Healthcare’s board since 2013. He is currently an Advisory Partner at Egis Capital Partners (Managing Partner, 2016–2023) and previously held CEO/CFO roles across energy logistics and specialty finance. He brings corporate finance, M&A, and operating expertise, and is classified by the board as an independent director (all directors independent other than the CEO) .
Past Roles
| Organization | Role | Tenure | Committees/Impact |
|---|---|---|---|
| Egis Capital Partners, LLC | Advisory Partner (Managing Partner 2016–2023) | 2016–2023 (MP); Advisory Partner current | Private equity investing in security/protection industries |
| Next Generation Energy Logistics, LLC | Chairman & CEO | 2013–2015 | Energy logistics development leadership |
| Pilot Logistics Services | Vice Chairman | Sep 2012–Jul 2013 | Drilling/exploration support services |
| Maxum Petroleum, Inc. | Chief Executive Officer | 2006–2012 | Independent energy logistics company CEO |
| Northwest Capital Appreciation, Inc. | Partner | Prior to 2006 | Merchant banking/private equity |
| SLP Capital | Co-Managing Partner & CFO | Prior to NCA | Specialty finance leadership and CFO |
External Roles
| Organization | Role | Public/Private | Tenure/Notes |
|---|---|---|---|
| Palmdale Solutions, LLC | Director | Private | Energy logistics platform |
| Clear Object, Inc. | Director | Private | AI video solutions provider |
| First Reserve Sustainable Growth Corp. (FRSG) | Director | Public (NASDAQ: FRSG) | 2021–2023 |
Board Governance
| Dimension | Details |
|---|---|
| Independence | Independent (board determined all directors independent except CEO) |
| Committees | Audit & Risk Committee (member); Nominating & Governance Committee (Chair); Finance Committee (member) |
| Audit Committee Expertise | Designated “audit committee financial expert” (Bissell, Fucci, Grieco, Kelly) and financially literate per SOX/NASDAQ/SEC rules |
| Committee Meetings (2024) | Audit & Risk: 5; Nominating & Governance: 5; Finance: 0 |
| Board Meetings (2024) | 5 meetings; each director attended ≥75% of board and committee meetings served |
| Skills Matrix Highlights | Health care; Real estate/project mgmt; Board/governance; Executive mgmt; Audit/finance/risk; M&A/strategic initiatives; IT/digital |
Fixed Compensation (Non-Employee Director Program)
| Component | Amount | Notes |
|---|---|---|
| Annual cash retainer | $87,000 | Paid at Annual Meeting Date |
| Audit & Risk member / chair | $15,000 / $30,000 | Per member/chair |
| Compensation member / chair | $12,500 / $27,500 | |
| Nominating & Governance member / chair | $10,000 / $22,000 | Bissell is Chair (eligible for $22,000) |
| Quality & Compliance member / chair | $12,500 / $27,500 | |
| Finance member / chair | $15,000 / $30,000 | Bissell is member (eligible for $15,000) |
| Lead Director / Non-exec Chair | $45,000 / $125,000 | If applicable |
| Annual director pay cap | $600,000 | Cash + equity |
| Retainer stock-in-lieu option | Available | Directors may elect shares for cash retainer; fully vested, based on prior-day close |
| Bissell – 2024 Director Compensation | Amount |
|---|---|
| Fees Earned or Paid in Cash | $139,000 |
| Stock Awards (grant date fair value) | $159,976 |
| Total | $298,976 |
Cross-check: Bissell’s cash fees align with plan math: $87,000 (board) + $22,000 (Nominating Chair) + $15,000 (Audit member) + $15,000 (Finance member) = $139,000 .
Performance Compensation
| Equity Type | Grant Details | Vesting | Value Basis |
|---|---|---|---|
| Annual time-vesting restricted stock | 2,414 shares granted May 23, 2024 to each non-management director | 3-year vesting, 33⅓% per year on successive anniversaries | Valued at prior-day close $66.27; grant date fair value $159,976 |
- No performance-vesting metrics apply to director equity; awards are time-vesting under the Directors Plan .
Other Directorships & Interlocks
| Category | Details |
|---|---|
| Current public boards | None disclosed for Bissell; prior service on First Reserve Sustainable Growth Corp. (NASDAQ: FRSG) 2021–2023 |
| Private/other boards | Palmdale Solutions, LLC; Clear Object, Inc. |
| Interlocks/conflicts | No board-disclosed interlocks with Acadia competitors/suppliers/customers for Bissell in 2025 proxy; related-person transactions are overseen by the Audit & Risk Committee under established procedures . |
Expertise & Qualifications
- Board identifies Bissell’s strengths in audit/finance/risk management, M&A/strategy, health care, real estate/project management, executive leadership, governance, and IT/digital, supporting his roles on Audit, Nominating (Chair), and Finance committees .
Equity Ownership
| Item | Amount/Status |
|---|---|
| Beneficial ownership (4/1/2025) | 38,623 shares; <1% of class (out of 92,127,804 shares outstanding) |
| Time-vesting restricted stock held (12/31/2024) | 4,669 shares (held by Bissell as of year-end) |
| Director ownership guidelines | 5x annual cash retainer; 5-year transition period; company states all non-management directors not in transition met guidelines as of 12/31/2024 |
| Hedging/pledging policy reference | Section titled “Stock Ownership Guidelines, Insider Trading Policy, Hedging and Pledging” appears; proxy details guidelines and references insider trading policy (specific hedging/pledging terms not detailed in retrieved excerpts) . |
| Retainer stock election | Directors may elect to receive cash retainers in fully vested shares at the prior-day close; subject to blackout windows and MNPI safeguards . |
Governance Assessment
- Strengths: Independent director; Chair of Nominating & Governance; Audit & Risk member and designated audit committee financial expert; multi-committee engagement; attendance ≥75%; equity-based compensation with 3-year vesting; director ownership guidelines met at board level (outside transition) .
- Alignment: 2024 comp mix balanced ($139k cash/$160k equity); ability to take retainers in stock; ongoing beneficial ownership (38,623 shares) supports skin-in-the-game, though <1% of class as expected for a large-cap .
- Potential watch items: Finance Committee did not meet in 2024 (may reflect limited transactional activity, but continued oversight expectations remain); otherwise, no Bissell-specific related-party transactions disclosed in retrieved excerpts; related-party approval resides with Audit & Risk Committee .
No red flags identified for conflicts, low attendance, or pay anomalies in the 2025 proxy excerpts reviewed. All directors except the CEO are independent; Bissell holds a leadership role on Nominating & Governance and is designated an audit committee financial expert, which generally supports board effectiveness and investor confidence .